Cooley and JunHe advised ImmuneOnco Biopharmaceuticals on the offering, and Kirkland & Ellis and Jingtian & Gongcheng advised the joint sponsors and underwriters. ImmuneOnco Biopharmaceuticals announced...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here